Cited by 104Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 264 of the 265 references it cites were found in a registry or an index.

APP Function and Lipids: A Bidirectional Link

Open access

Grimm, Marcus O. W., Mett, Janine, Grimm, Heike S., Hartmann, Tobias·2017·Frontiers in Molecular Neuroscience

DOI 10.3389/fnmol.2017.00063PMC PMC5344993

Open this paper in CoChat — free account Open PDF

Abstract

Extracellular neuritic plaques, composed of aggregated amyloid-β (Aβ) peptides, are one of the major histopathological hallmarks of Alzheimer’s disease (AD), a progressive, irreversible neurodegenerative disorder and the most common cause of dementia in the elderly. One of the most prominent risk factor for sporadic AD, carrying one or two aberrant copies of the apolipoprotein E (ApoE) ɛ4 alleles, closely links AD to lipids. Further, several lipid classes and fatty acids have been reported to be changed in the brain of AD-affected individuals. Interestingly, the observed lipid changes in the brain seem not only to be a consequence of the disease but also modulate Aβ generation. In line with these observations protective lipids being able to decrease Aβ generation and also potential negative lipids in respect to AD were identified. Mechanistically, Aβ peptides are generated by sequential proteolytic processing of the amyloid precursor protein (APP) by β- and γ-secretase. The α-secretase appears to compete with β-secretase for the initial cleavage of APP, preventing Aβ production. All APP-cleaving secretases as well as APP are transmembrane proteins, further illustrating the impact of lipids on Aβ generation. Beside the pathological impact of Aβ, accumulating evidence suggests that Aβ and the APP intracellular domain (AICD) play an important role in regulating lipid homeostasis, either by direct effects or by affecting gene expression or protein stability of enzymes involved in the de novo synthesis of different lipid classes. This review summarizes the current literature addressing the complex bidirectional link between lipids and AD and APP processing including lipid alterations found in AD post mortem brains, lipids that alter APP processing and the physiological functions of Aβ and AICD in the regulation of several lipid metabolism pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3389/fnmol.2017.00063

Cites

264 of 264 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Overview of the two alternative amyloid precursor protein (APP) processing pathways, which are highly influenced by lipid homeostasis. Amyloidogenic pathway: APP is first cleaved by the β-secretase β-site APP cleaving enzyme 1 (BACE1) resulting in the release of sAPPβ and the generation of C99, which is further processed by the γ-secretase complex to amyloid-β (Aβ)-peptides and the APP intracellular domain (AICD). The neurotoxic Aβ-peptides can be cleared by different mechanisms including enzymatic degradation. The intracellular AICD-domain is known to translocate into the nucleus and to regulate the transcription of several target genes. Non-amyloidogenic pathway: APP is cleaved by the α-secretases belonging to the ADAM protein family within the Aβ-domain. This results in the release of sAPPα into the extracellular space and the formation of C83. C83 is further processed by the γ-secretase complex resulting in the release of the non-toxic peptide p3 into the extracellular space and of AICD into the cytosol. In contrast to the AICD generated by amyloidogenic APP processing the AICD derived from α-/γ-secretase-dependent APP processing is rapidly degraded in the cytosol and transcriptionally inactive.CC BY · PubMed Central

Figure 2 Summary of the bidirectional link between proteolytic processing of the APP and lipid homeostasis. In brain tissue affected by Alzheimer’s disease (AD) the levels of several lipid classes and fatty acids are altered (indicated by ↓ = decreased, ↑ = increased). Lipids and fatty acids have a strong impact on the cerebral Aβ-levels and there is also a regulation of lipid homeostasis by the APP-processing products Aβ and AICD (delineated by + = increasing effect, − = decreasing effect) indicating the existence of complex regulatory cycles between lipid homeostasis and proteolytic APP processing (green arrows = beneficial effects, red arrows = negative effects, gray arrows = neutral/unknown effects). AGPS, alkyl-dihydroxyacetonephosphate-synthase; DHA, docosahexaenoic acid; GCS, glycosylceramide synthase; GD3S, GD3-synthase; HMGCR, hydroxymethylglutaryl-CoA reductase; PLA2, phospholipase A2; S1P, sphingosine 1-phosphate; SMases, sphingomyelinases; SPT, the serine palmitoyl-CoA transferase.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

2 retracted

RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
Retracted
Ceramide Stabilizes β-Site Amyloid Precursor Protein-cleaving Enzyme 1 and Promotes Amyloid β-Peptide Biogenesis
Puglielli, L., Ellis, B. C., Saunders, A. J., & Kovacs, D. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300466200 · Cited by 265
Retracted
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Lipid rafts as a membrane-organizing principle
Lingwood, D., & Simons, K. (2010) · Science · doi:10.1126/science.1174621 · Cited by 4,417

Show all 265 references

Research works printed but not linked: 1

World Alzheimer Report, 2015, Alzheimer’s Disease International

Sorted by citations

Surgery, neuroinflammation and cognitive impairment
Alam, A., Hana, Z., Jin, Z., Suen, K. C., & Ma, D. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.021 · Cited by 495
Application of Metabolomics in Alzheimer’s Disease
Wilkins, J. M., & Trushina, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2017.00719 · Cited by 268
Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer’s Disease
Yang, J., Wang, Z., Cai, H.-Y., Li, Y., Hu, M.-M., Wu, M., & Qi, J. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0268-9 · Cited by 168
Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods
van Kruining, D., Luo, Q., van Echten‐Deckert, G., Mielke, M. M., Bowman, A. P., Ellis, S. R., Oliveira, T. G., & Martínez‐Martínez, P. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.04.009 · Cited by 138
Lipid Profiling of Alzheimer’s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism
Akyol, S., Ugur, Z., Yılmaz, A., Ustun, I., Gorti, S. K. K., Oh, K., McGuinness, B., Passmore, P., Kehoe, P. G., Maddens, M. E., et al. (2021) · Cells · doi:10.3390/cells10102591 · Cited by 138
β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
Penke, B., Bogár, F., & Fülöp, L. (2017) · Molecules · doi:10.3390/molecules22101692 · Cited by 150
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126
“Indeed, there is evidence that alternative APP-derived fragments as well as APP itself play important roles in the modulation of immune cell activation [160], protein clearance [161], and lipid homeostasis [162].”
Background
Omega-3 fatty acids, lipids, and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention
Grimm, M. O. W., Michaelson, D. M., & Hartmann, T. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076331 · Cited by 114
Self-citation
ATAD3A oligomerization promotes neuropathology and cognitive deficits in Alzheimer’s disease models
Zhao, Y., Hu, D., Wang, R., Sun, X., Ropelewski, P., Hubler, Z. M. L., Lundberg, K. C., Wang, Q., Adams, D., Xu, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28769-9 · Cited by 98
Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer’s Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry
Kaya, I., Zetterberg, H., Blennow, K., & Hanrieder, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00121 · Cited by 87
Sphingolipids in Alzheimer's disease, how can we target them?
Crivelli, S. M., Giovagnoni, C., Visseren, L., Scheithauer, A.-L., de Wit, N. M., den Hoedt, S., Losen, M. H., Mulder, M. T., Walter, J., de Vries, H. E., et al. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.12.003 · Cited by 88
Cholesterol Metabolism in Aging and Age-Related Disorders
Saher, G. (2023) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-091922-034237 · Cited by 88
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 76
APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain
Lefterov, I., Wolfe, C. M., Fitz, N. F., Nam, K. N., Letronne, F., Biedrzycki, R. J., Kofler, J., Han, X., Wang, J., Schug, J., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0558-0 · Cited by 74
Phospholipase D3 degrades mitochondrial DNA to regulate nucleotide signaling and APP metabolism
Acker, Z. P. V., Perdok, A., Hellemans, R., North, K., Vorsters, I., Cappel, C. C., Dehairs, J., Swinnen, J. V., Sannerud, R., Bretou, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38501-w · Cited by 76
Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
He, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62
Shared Causal Paths underlying Alzheimer’s dementia and Type 2 Diabetes
Hu, Z., Jiao, R., Wang, P., Zhu, Y., Zhao, J., Jager, P. L. D., Bennett, D. A., Li, J., & Xiong, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-60682-3 · Cited by 63
Presenilins and γ-Secretase in Membrane Proteostasis
Oikawa, N., & Walter, J. (2019) · Cells · doi:10.3390/cells8030209 · Cited by 65
PPARβ/δ‐agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes
Konttinen, H., Gureviciene, I., Oksanen, M., Grubman, A., Loppi, S. H., Huuskonen, M. T., Korhonen, P., Lampinen, R., Keuters, M. H., Belaya, I., et al. (2018) · Glia · doi:10.1002/glia.23534 · Cited by 52
Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells
Fanaee‐Danesh, E., Gali, C. C., Tadić, J., Zandl‐Lang, M., Kober, A. C., Agujetas, V. R., de Dios, C., Tam‐Amersdorfer, C., Stracke, A., Albrecher, N. M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.019 · Cited by 53
Preferred Endocytosis of Amyloid Precursor Protein from Cholesterol-Enriched Lipid Raft Microdomains
Cho, Y. Y., Kwon, O.-H., & Chung, S. (2020) · Molecules · doi:10.3390/molecules25235490 · Cited by 51
Key Peptides and Proteins in Alzheimer’s Disease
Penke, B., Bogár, F., Paragi, G., Gera, J., & Fülöp, L. (2019) · Current Protein and Peptide Science · doi:10.2174/1389203720666190103123434 · Cited by 51
Paraoxonase Role in Human Neurodegenerative Diseases
Reichert, C. O., Levy, D., & Bydlowski, S. P. (2020) · Antioxidants · doi:10.3390/antiox10010011 · Cited by 53
Lipidomic alterations in lipoproteins of patients with mild cognitive impairment and Alzheimer’s disease by asymmetrical flow field-flow fractionation and nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry
Kim, S. H., Yang, J. S., Lee, J. C., Lee, J.-Y., Lee, J., Kim, E., & Moon, M. H. (2018) · Journal of Chromatography A · doi:10.1016/j.chroma.2018.07.018 · Cited by 47
Amyloid-Mediated Mechanisms of Membrane Disruption
Sciacca, M. F. M., Rosa, C. L., & Milardi, D. (2021) · Biophysica · doi:10.3390/biophysica1020011 · Cited by 45
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
Sáez-Orellana, F., Octave, J., & Pierrot, N. (2020) · Cells · doi:10.3390/cells9051215 · Cited by 47
Lipid-Binding Proteins in Brain Health and Disease
Corraliza-Gómez, M., Sánchez, D., & Ganfornina, M. D. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01152 · Cited by 43
The Impact of Medium Chain and Polyunsaturated ω-3-Fatty Acids on Amyloid-β Deposition, Oxidative Stress and Metabolic Dysfunction Associated with Alzheimer’s Disease
Mett, J. (2021) · Antioxidants · doi:10.3390/antiox10121991 · Cited by 43
Self-citation
Early signature in the blood lipidome associated with subsequent cognitive decline in the elderly: A case-control analysis nested within the Three-City cohort study
Lefèvre‐Arbogast, S., Hejblum, B. P., Helmer, C., Klose, C. D., Manach, C., Low, D. Y., Urpí-Sardà, M., Andrés‐Lacueva, C., González‐Domínguez, R., Aigner, L., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103216 · Cited by 40
Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
Trushina, E. V. (2019) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.06.008 · Cited by 35
DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice
Zhang, W.-B., Huang, Y. M., Guo, X., Zhang, M.-Q., Yuan, X.-S., & Zu, H. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01593-y · Cited by 35
Real-time nanoscale organization of amyloid precursor protein
Kedia, S., Ramakrishna, P., Netrakanti, P. R., Jose, M., Sibarita, J., Nadkarni, S., & Nair, D. K. (2020) · Nanoscale · doi:10.1039/d0nr00052c · Cited by 33
The interplay between lipid and Aβ amyloid homeostasis in Alzheimer’s Disease: risk factors and therapeutic opportunities
García‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 34
Peripheral Mitochondrial Dysfunction: A Potential Contributor to the Development of Metabolic Disorders and Alzheimer’s Disease
Sultana, M. A., Hia, R. A., Akinsiku, O., & Hegde, V. K. (2023) · Biology · doi:10.3390/biology12071019 · Cited by 31
The role of UNC5C in Alzheimer’s disease
Li, Q., Wang, B.-L., Sun, F.-R., Li, J., Cao, X., & Tan, L. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.43 · Cited by 29
Structural Studies Providing Insights into Production and Conformational Behavior of Amyloid-β Peptide Associated with Alzheimer’s Disease Development
Urban, A. S., Pavlov, K. V., Kamynina, A. V., Okhrimenko, I. S., Arseniev, A. S., & Bocharov, E. V. (2021) · Molecules · doi:10.3390/molecules26102897 · Cited by 30
ApoE isoforms and carboxyl-terminal-truncated apoE4 forms affect neuronal BACE1 levels and Aβ production independently of their cholesterol efflux capacity
Dafnis, I., Raftopoulou, C., Mountaki, C., Megalou, E. V., Zannis, V. I., & Chroni, A. (2018) · Biochemical Journal · doi:10.1042/bcj20180068 · Cited by 29
Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF
Torretta, E., Arosio, B., Barbacini, P., Capitanio, D., Rossi, P. D., Moriggi, M., Clerici, M., Mari, D., Cesari, M., & Gelfi, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158034 · Cited by 27
Membrane lipid remodeling modulates γ-secretase processivity
Dawkins, E., Derks, R. J. E., Schifferer, M., Trambauer, J., Winkler, E., Simons, M., Paquet, D., Giera, M. A., Kamp, F., & Steiner, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.103027 · Cited by 29
The C99 domain of the amyloid precursor protein resides in the disordered membrane phase
Capone, R. F., Tiwari, A., Hadziselimovic, A., Peskova, Y. B., Hutchison, J. M., Sanders, C. R., & Kenworthy, A. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100652 · Cited by 28
Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells
Theiss, E. L., Griebsch, L. V., Lauer, A. A., Janitschke, D., Erhardt, V. K. J., Haas, E. C., Kuppler, K. N., Radermacher, J., Walzer, O., Portius, D., et al. (2022) · Cells · doi:10.3390/cells11162574 · Cited by 24
Self-citation
Spatially resolved mass spectrometry analysis of amyloid plaque‐associated lipids
Blank, M., & Hopf, C. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15216 · Cited by 24
Medium-Chain Length Fatty Acids Enhance Aβ Degradation by Affecting Insulin-Degrading Enzyme
Mett, J., Lauer, A. A., Janitschke, D., Griebsch, L. V., Theiss, E. L., Grimm, H. S., Koivisto, H., Tanila, H., Hartmann, T., & Grimm, M. O. W. (2021) · Cells · doi:10.3390/cells10112941 · Cited by 24
Self-citation
Lipids and lipoproteins may play a role in the neuropathology of Alzheimer’s disease
Akyol, Ö., Akyol, S., Chou, M., Chen, S., Liu, C., Selek, S., Soares, J. C., & Chen, C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1275932 · Cited by 27
Cellular hormetic response to 27-hydroxycholesterol promotes neuroprotection through AICD induction of MAST4 abundance and kinase activity
Gongol, B., Marin, T., Jeppson, J. D., Mayagoitia, K., Shin, S. D., Sanchez, N., Kirsch, W. M., Vinters, H. V., Wilson, C. G., Ghribi, O., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13933-9 · Cited by 23
Short-Term Fish Oil Treatment Changes the Composition of Phospholipids While Not Affecting the Expression of Mfsd2a Omega-3 Transporter in the Brain and Liver of the 5xFAD Mouse Model of Alzheimer’s Disease
Milanović, D., Petrović, S., Brkić, M., Avramović, V., Perović, M., Ivković, S., Glibetić, M., & Kanazir, S. (2018) · Nutrients · doi:10.3390/nu10091250 · Cited by 27
FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer’s disease expressing APOE4
Crivelli, S. M., Luo, Q., van Kruining, D., Giovagnoni, C., Mané-Damas, M., den Hoedt, S., Berkeš, D., de Vries, H. E., Mulder, M. T., Walter, J., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113240 · Cited by 23
Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer's disease
Kedia, S., Ramakrishna, P., Netrakanti, P. R., Singh, N., Sisodia, S. S., Jose, M., Kumar, S., Mahadevan, A., Ramanan, N., Nadkarni, S., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101924 · Cited by 21
The mechanism of bile acid metabolism regulating lipid metabolism and inflammatory response in T2DM through the gut-liver axis
Wang, Y., Lv, B., Liu, N., Tao, S., Dou, J., Li, J., Deng, R., Yang, X., & Jiang, G. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35421 · Cited by 21
Glycosylation status of nicastrin influences catalytic activity and substrate preference of γ-secretase
Moniruzzaman, M., Ishihara, S., Nobuhara, M., Higashide, H., & Funamoto, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.126 · Cited by 21
Acral melanoma in skin of color: current insights and future directions: a narrative review
Nadelmann, E., Singh, A., Abbruzzese, M., Adeuyan, O., Kenchappa, D., Kovrizhkin, K., Lightman, M., Samouha, A., Tao, K., Yun, J., et al. (2025) · Cancers · doi:10.3390/cancers17030468 · Cited by 20
Structural Determinant of β-Amyloid Formation: From Transmembrane Protein Dimerization to β-Amyloid Aggregates
Papadopoulos, N., Suelves, N., Perrin, F., Vadukul, D. M., Vrancx, C., Constantinescu, S. N., & Kienlen-Campard, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112753 · Cited by 20
When lipid homeostasis runs havoc: Lipotoxicity links lysosomal dysfunction to autophagy
Tegeder, I., & Kögel, D. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.11.005 · Cited by 20
Shotgun lipidomics of liver and brain tissue of Alzheimer’s disease model mice treated with acitretin
Lauer, A. A., Janitschke, D., Guilherme, M. D. S., Nguyen, V. T. T., Bachmann, C. M., Qiao, S., Schrul, B., Boehm, U., Grimm, H. S., Hartmann, T., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94706-3 · Cited by 18
Self-citation
A Targeted Mass Spectrometry Approach to Identify Peripheral Changes in Metabolic Pathways of Patients with Alzheimer’s Disease
Reveglia, P., Paolillo, C., Angiolillo, A., Ferretti, G., Angelico, R., Sirabella, R., Corso, G., Matrone, C., & Costanzo, A. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119736 · Cited by 17
Modulation of Mitochondrial Function as a Therapeutic Strategy for Neurodegenerative Diseases
Trushina, E. V., Nguyen, T. K. O., & Trushin, S. (2023) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2023.108 · Cited by 17
In vitro Neuroprotective Potential and Lipidomics Study of Olive Leaves Extracts Enriched in Triterpenoids
Gallego, R., Suárez-Montenegro, Z. J., Ibáñez, E., Herrero, M., Valdés, A., & Cifuentes, A. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.769218 · Cited by 19
A bidirectional link between sulfatide and Alzheimer’s disease
Zimmer, V. C., Lauer, A. A., Haupenthal, V. J., Stahlmann, C. P., Mett, J., Grösgen, S., Hundsdörfer, B., Rothhaar, T. L., Endres, K., Eckhardt, M., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.10.021 · Cited by 17
Self-citation
Neuroprotective Effects of Resveratrol by Modifying Cholesterol Metabolism and Aβ Processing in SAMP8 Mice
Sánchez-Melgar, A., Izquierdo-Ramírez, P. J., Griñán‐Ferré, C., Pallàs, M., Martín, M., & Albasanz, J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147580 · Cited by 17
All- d -Enantiomeric Peptide D3 Designed for Alzheimer’s Disease Treatment Dynamically Interacts with Membrane-Bound Amyloid-β Precursors
Bocharov, E. V., Gremer, L., Urban, A. S., Okhrimenko, I. S., Volynsky, P. E., Nadezhdin, K. D., Bocharova, O. V., Kornilov, D. A., Zagryadskaya, Y. A., Kamynina, A. V., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00632 · Cited by 14
Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer’s Disease Pathogenesis
Bocharov, E. V., Nadezhdin, K. D., Urban, A. S., Volynsky, P. E., Pavlov, K. V., Efremov, R. G., Arseniev, A. S., & Bocharova, O. V. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00309 · Cited by 15
The impact of capsaicinoids on APP processing in Alzheimer’s disease in SH-SY5Y cells
Grimm, M. O. W., Blümel, T., Lauer, A. A., Janitschke, D., Stahlmann, C. P., Mett, J., Haupenthal, V. J., Miederer, A.-M., Niemeyer, B. A., Grimm, H. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-66009-6 · Cited by 15
Self-citation
Micro-Raman spectroscopy of lipid halo and dense-core amyloid plaques: aging process characterization in the Alzheimer's disease APPswePS1ΔE9 mouse model
Fonseca, E. A., Lafetá, L., Campos, J. L. E., Cunha, R. S., Barbosa, A. S., Romano‐Silva, M. A., Vieira, R. P., Malard, L. M., & Jório, A. (2021) · The Analyst · doi:10.1039/d1an01078f · Cited by 15
Who's in, who's out? Re‐evaluation of lipid raft residents
Mlinac, K., Ilić, K., Zjalić, M., Mandić, D., Debeljak, Ž., Balog, M., Damjanović, V., Hrvat, N. M., Habek, N., Bognar, S. K., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15446 · Cited by 14
A Lipid-Raft Theory of Alzheimer's Disease
Rappoport, A. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052024-115455 · Cited by 15
Membrane Cholesterol Is a Critical Determinant for Hippocampal Neuronal Polarity
Jose, M., Sivanand, A., & Channakeshava, C. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.746211 · Cited by 13
In vivo evidence of cortical amyloid deposition in the adult form of Niemann Pick type C
Esposito, M., Dubbioso, R., Tozza, S., Iodice, R., Aiello, M., Nicolai, E., Cavaliere, C., Salvatore, M., Santoro, L., & Manganelli, F. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e02776 · Cited by 13
New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD
Yang, X., Yao, K., Zhang, M., Zhang, W., & Zu, H. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111321 · Cited by 12
Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review
Carbone, M. G., Pagni, G., Tagliarini, C., Marazziti, D., & Pomara, N. (2021) · Life · doi:10.3390/life11080750 · Cited by 11
Effects of chain length of saturated fatty acids on Aβ generation in SH-SY5Y cells
Liu, J.-J., Zhang, W., Wang, S., Jia, Z., Shi, Y., Yang, L., & Shi, R. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.024 · Cited by 9
Disturbances in PP2A methylation and one-carbon metabolism compromise Fyn distribution, neuritogenesis, and APP regulation
Taleski, G., Schuhmacher, D., Su, H. K., Sontag, J., & Sontag, E. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016069 · Cited by 10
Tau/Aβ chimera peptides: A Thioflavin-T and MALDI-TOF study of Aβ amyloidosis in the presence of Cu(II) or Zn(II) ions and total lipid brain extract (TLBE) vesicles
Sciacca, M. F. M., Natale, G. D., Milardi, D., & Pappalardo, G. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105085 · Cited by 10
The oxidative aging model integrated various risk factors in type 2 diabetes mellitus at system level
Chen, Y., Yao, L., Zhao, S., Xu, M., Ren, S., Xie, L., Liu, L., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1196293 · Cited by 9
Origins of nervous tissue susceptibility to ferroptosis
Snyder, J., & Wu, Z. (2023) · Cell Insight · doi:10.1016/j.cellin.2023.100091 · Cited by 10
Cellular cholesterol loss by DHCR24 knockdown leads to Aβ production by changing APP intracellular localization
Huang, Y. M., Zhang, W., Guo, X., Zhang, Y., Wu, J., & Zu, H. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100367 · Cited by 9
Methylxanthines Induce a Change in the AD/Neurodegeneration-Linked Lipid Profile in Neuroblastoma Cells
Janitschke, D., Lauer, A. A., Bachmann, C. M., Winkler, J., Griebsch, L. V., Pilz, S. M., Theiss, E. L., Grimm, H. S., Hartmann, T., & Grimm, M. O. W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042295 · Cited by 8
Self-citation
Covalent modifications of the amyloid beta peptide by hydroxynonenal: Effects on metal ion binding by monomers and insights into the fibril topology
Grasso, G., Komatsu, H., & Axelsen, P. H. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.007 · Cited by 8
Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
Qurban, A., Zhang, M., Zu, H., & Yao, K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27111 · Cited by 6
Diverse Interactions of Sterols with Amyloid Precursor Protein Transmembrane Domain Can Shift Distribution Between Alternative Amyloid-β Production Cascades in Manner Dependent on Local Lipid Environment
Volynsky, P. E., Urban, A. S., Pavlov, K. V., Bershatsky, Y. V., Bocharova, O. V., Kryuchkova, A. K., Zlobina, V. V., Gavrilenkova, A. A., Dolotova, S. M., Kamynina, A. V., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020553 · Cited by 7
Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells
Bachmann, C. M., Janitschke, D., Lauer, A. A., Erhardt, T., Hartmann, T., Grimm, M. O. W., & Grimm, H. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032972 · Cited by 5
Self-citation
Astaxanthin alleviates ganglioside metabolism disorder in the cortex of Alzheimer's disease mice
Wang, Z., Wang, X., Ma, Y., Cong, P., Wang, X., Song, Y., Xu, J., & Xue, C. (2023) · Food & Function · doi:10.1039/d3fo03223j · Cited by 5
Lipidomics
Benedusi, V. (2018) · Materials and Methods · doi:10.13070/mm.en.8.2665 · Cited by 5
Neuronal endolysosomal alterations induced by Apolipoprotein E4 emerge over time in primary neurons
Nyberg, E., Konings, S. C., Lindblom, N., Israelsson, B., Klementieva, O. L., Martinsson, I., & Gouras, G. K. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110479 · Cited by 3
Exploring the connection between dementia and cardiovascular risk with a focus on ADAM10
Targas, A. B. A., Victoriano, P. H. M., Garcia, M. B. B., Alexandre-Silva, V., & Cominetti, M. R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167825 · Cited by 3
A VEGF Fragment Encompassing Residues 10–30 Inhibits Aβ1–42 Amyloid Aggregation and Exhibits Neuroprotective Properties Matching the Full-Length Protein
Zimbone, S., Giuffrida, M. L., Sciacca, M. F. M., Carrotta, R., Librizzi, F., Milardi, D., & Grasso, G. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00669 · Cited by 3
Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer’s Disease
Khadgawat, P., Siddesha, J. M., Shashank, D., & Shashanka, K. P. (2021) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210018 · Cited by 4
Transient cholesterol interactions with the amyloid precursor protein involved in Alzheimer’s disease pathogenesis
Zlobina, V. V., Mitkevich, V. A., Bershatsky, Y. V., Volynsky, P. E., Pavlov, K. V., Karbyshev, M. S., Okhrimenko, I. S., Kozin, S. A., Efremov, R. G., Makarov, A. А., et al. (2025) · Biophysical Reviews · doi:10.1007/s12551-025-01358-y · Cited by 2
Cetoleic acid and other long-chain unsaturated fatty acids as neuroprotective nutraceuticals
Tang, P., Ruiz-Pastor, M. J., Lewis, A. E., Fladmark, K. E., Kobro-Flatmoen, A., Halskau, Ø., & Lal, P. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-026-02876-8 · Cited by 2
A lipid-raft theory of Alzheimer's disease
Rappoport, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-44-345008-2.00017-5 · Cited by 2
Unveiling ribosomal dysfunction and impaired signaling pathways in the cortical region of 5xFAD mice
Agrawal, K., Egbejiogu, B. C., Adeyelu, T. T., Burk, D., Murray, K. K., Walls, A. W., Jones, K. A., Campagna, S. R., Francis, J., Ghosh, S., et al. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02254-6 · Cited by 1
Effect of hypercholestermic diet on the amyloid precursor protein (APP) deposition with some behavior alterations in male rats
Raheem, H. A., Albazi, W. J., Altaee, R., & Jhoni, G. H. (2023) · Journal of Kerbala for Agricultural Sciences · doi:10.59658/jkas.v10i2.1188 · Cited by 1
Potential Candidate Genes and Pathways Affecting the Metabolism of Jaw Fats in Risso’s Dolphin: Based on TranscriptomicsPreprint
Senevirathna, J. D. M., Yonezawa, R., Igarashi, Y., Saka, T., Yoshitake, K., Kinoshita, S., Funasaka, N., & Asakawa, S. (2021) · Research Square · doi:10.21203/rs.3.rs-144280/v1 · Cited by 1
Exploring sphingolipid function in the pathogenesis of Alzheimer’s disease
Luo, Q. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220215ql
Rodent models of Alzheimer’s disease
Kasza, Á. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9743
The effect of PC20:0 and di-C7-PC amphiphilic surfactants on the aggregation of Aβ1–40 and Aβ1–42 using molecular dynamics simulation
Abdulkareem, S. M., Housaindokht, M. R., & Bozorgmehr, M. R. (2023) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-023-02761-6
Taliglucerase Alfa Modulates Aβ Load and Autophagy-Related Pathways in Mouse Hippocampal Neurons Exposed to oAβ1-42Preprint
Özkurt, Ç., Köse, S., Karasu, Ç., Kortholt, A., & Kelicen‐Uğur, P. (2025) · Research Square · doi:10.21203/rs.3.rs-7094261/v1
Additional file 2 of DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice
Zhang, W.-B., Huang, Y., Guo, X.-R., Zhang, M.-Q., 袁向山, & Zu, H.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26598869
Additional file 1 of DHCR24 reverses Alzheimer’s disease-related pathology and cognitive impairment via increasing hippocampal cholesterol levels in 5xFAD mice
Zhang, W.-B., Huang, Y., Guo, X.-R., Zhang, M.-Q., 袁向山, & Zu, H.-B. (2024) · Figshare · doi:10.6084/m9.figshare.26598866
Étude épidémiologique de la relation entre exposome alimentaire et vieillissement cérébral : du nutriment candidat à une approche systémique
Lefèvre‐Arbogast, S. (2019) · theses.fr (ABES) · doi:10.70675/6915e632z663fz4caaz9c7az455ad25755da
Les APP-CTFs au cœur du processus pathologique de la maladie d’Alzheimer : contribution du système lysosomal-autophagique et de la sécrétion exosomale
Bécot, A. (2019) · theses.fr (ABES) · doi:10.70675/21765754zb9e7z40f9zb951z367e5fa4bcac

Authors: Grimm, M. O. W., Mett, J., Grimm, H. S., & Hartmann, T.
Affiliations: Saarland University (DE)
Corresponding author: Grimm, Marcus O. W.
ORCID: Grimm, Marcus O. W.
Mett, Janine
Grimm, Heike S.
Hartmann, Tobias
Venue: Frontiers in Molecular Neuroscience
Publisher: Frontiers Media SA
Published: 2017-03-10
Volume: 10
Pages: 63-63
ISSN: 1662-5099 (ISSN-L)
DOI: 10.3389/fnmol.2017.00063
PMC: PMC5344993
OpenAlex: W2594288299
Cited by: 104
References: 265
Citations by year: 2026: 6 · 2025: 10 · 2024: 5 · 2023: 17 · 2022: 7 · 2021: 19 · 2020: 13 · 2019: 11 · 2018: 12 · 2017: 4
FWCI: 1.34
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
Locations: Frontiers in Molecular Neuroscience (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: EU Joint Programme – Neurodegenerative Disease Research
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, amyloid-beta, amyloid precursor protein, APOE ε4, lipid metabolism, beta-secretase, gamma-secretase, alpha-secretase, APP intracellular domain, lipid homeostasis, fatty acids, neuritic plaques, lipid dysregulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

APP Function and Lipids: A Bidirectional Link

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks